Pages that link to "Q47971155"
Jump to navigation
Jump to search
The following pages link to Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice (Q47971155):
Displaying 50 items.
- Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice (Q24602785) (← links)
- The crystal structure and mode of action of trans-sialidase, a key enzyme in Trypanosoma cruzi pathogenesis (Q27639917) (← links)
- Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection (Q30452989) (← links)
- Epitope mapping of trans-sialidase from Trypanosoma cruzi reveals the presence of several cross-reactive determinants (Q30652825) (← links)
- Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection (Q30947127) (← links)
- DNA vaccines and their application against parasites--promise, limitations and potential solutions. (Q33208276) (← links)
- The non-palindromic adaptor-PCR method for the identification of the T-cell receptor genes of an interferon-gamma-secreting T-cell hybridomaspecific for trans-sialidase, an immunodominant Trypanosoma cruzi antigen (Q33234761) (← links)
- DNA vaccines: technology and application as anti-parasite and anti-microbial agents (Q33537293) (← links)
- DNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection (Q33597941) (← links)
- Genetic immunization converts the trypanosoma cruzi B-Cell mitogen proline racemase to an effective immunogen (Q33613943) (← links)
- Vaccination with peptide mimotopes produces antibodies recognizing bacterial capsular polysaccharides (Q33646360) (← links)
- Trans-sialidase delivered as a naked DNA vaccine elicits an immunological response similar to a Trypanosoma cruzi infection (Q33646690) (← links)
- Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice (Q33656471) (← links)
- Intranasal vaccinations with the trans-sialidase antigen plus CpG Adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges. (Q33675887) (← links)
- Co-Administration of a Plasmid DNA Encoding IL-15 Improves Long-Term Protection of a Genetic Vaccine against Trypanosoma cruzi (Q33847435) (← links)
- Genetic vaccination against experimental infection with myotropic parasite strains of Trypanosoma cruzi (Q33902471) (← links)
- CD8(+) T cell-mediated immunity during Trypanosoma cruzi infection: a path for vaccine development? (Q33914939) (← links)
- DNA vaccines for viral infections: basic studies and applications (Q33923010) (← links)
- Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene. (Q34001352) (← links)
- DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene (Q34008901) (← links)
- CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2. (Q34034104) (← links)
- Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection (Q34075166) (← links)
- Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice (Q34130172) (← links)
- Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection (Q34131388) (← links)
- The Trypanosoma cruzi flagellum is discarded via asymmetric cell division following invasion and provides early targets for protective CD8⁺ T cells (Q34324298) (← links)
- Parasite genomics: current status and future prospects (Q34332632) (← links)
- Advances and prospects for subunit vaccines against protozoa of veterinary importance (Q34438102) (← links)
- Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection (Q34801770) (← links)
- Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease (Q35011455) (← links)
- Antigen targeting to dendritic cells allows the identification of a CD4 T-cell epitope within an immunodominant Trypanosoma cruzi antigen (Q35095495) (← links)
- Trypanosoma cruzi trans-sialidase prevents elicitation of Th1 cell response via interleukin 10 and downregulates Th1 effector cells (Q35439736) (← links)
- A DNA vaccine encoding for TcSSP4 induces protection against acute and chronic infection in experimental Chagas disease (Q35565140) (← links)
- Sialoglycans in protozoal diseases: their detection, modes of acquisition and emerging biological roles (Q35748332) (← links)
- Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity (Q36136972) (← links)
- DNA vaccines against tropical parasitic diseases (Q36238733) (← links)
- Current status and future prospects for a vaccine against American trypanosomiasis (Q36350576) (← links)
- The Trypanosoma cruzi trans-sialidase, through its COOH-terminal tandem repeat, upregulates interleukin 6 secretion in normal human intestinal microvascular endothelial cells and peripheral blood mononuclear cells (Q36375616) (← links)
- Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice (Q36844866) (← links)
- Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' disease (Q36844914) (← links)
- DNA Vaccines against Protozoan Parasites: Advances and Challenges (Q36915067) (← links)
- Free energy study of the catalytic mechanism of Trypanosoma cruzi trans-sialidase. From the Michaelis complex to the covalent intermediate. (Q37189253) (← links)
- Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening (Q37582887) (← links)
- Invasion-inhibitory antibodies elicited by immunization with Plasmodium vivax apical membrane antigen-1 expressed in Pichia pastoris yeast (Q37643896) (← links)
- DNA vaccines: a rational design against parasitic diseases. (Q37682900) (← links)
- Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate (Q39007706) (← links)
- Trans-sialidase from Trypanosoma brucei as a potential target for DNA vaccine development against African trypanosomiasis (Q39463391) (← links)
- Perspectives of vaccination in Chagas disease revisited (Q39945086) (← links)
- The genetic immunization with paraflagellar rod protein-2 fused to the HSP70 confers protection against late Trypanosoma cruzi infection (Q40244977) (← links)
- Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection. (Q43550922) (← links)
- Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2. (Q43591184) (← links)